Results 31 to 40 of about 3,465 (162)

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis. [PDF]

open access: yes, 2015
Objective Human leucocyte antigen (HLA)-B27 and endoplasmic reticulum aminopeptidase 1 (ERAP1) are strongly associated with ankylosing spondylitis (AS).
Bowness, Paul   +11 more
core   +2 more sources

ERAP1 inhibitor development [PDF]

open access: yes, 2018
ERAP1 has been associated with a set of immune-mediated diseases, including ankylosing spondylitis. Currently, there is no selective and potent ERAP1 inhibitor available that would allow in-depth research of its functions and roles in diseases. Therefore,

core   +1 more source

Molecular Backgrounds of ERAP1 Downregulation in Cervical Carcinoma

open access: yesAnalytical Cellular Pathology, 2015
The antigen processing machinery (APM) plays an important role in immune recognition of virally infected and transformed cells. Defective expression of the APM component ERAP1 is associated with progression and poor clinical outcome in cervical carcinoma.
Akash M. Mehta   +4 more
doaj   +1 more source

The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities

open access: yesFrontiers in Immunology, 2022
IntroductionCritical steps in Major Histocompatibility Complex Class I (MHC-I) antigen presentation occur in the endoplasmic reticulum (ER). In general, peptides that enter the ER are longer than the optimal length for MHC-I binding.
Adrian Martín-Esteban   +6 more
doaj   +1 more source

The role of ERAP1 and HLA-B27 in ankylosing spondylitis pathogenesis [PDF]

open access: yes, 2016
HLA-B27 and ERAP1 are the two strongest predisposing genetic factors to Ankylosing Spondylitis (AS). As a key aminopeptidase in MHC class I presentation, ERAP1 potentially contributes to AS pathogenesis through altering HLA-B27 peptide presentation.

core   +1 more source

The design, synthesis and optimisation of small molecule ERAP1 inhibitors

open access: yes, 2022
Previously held under moratorium in the Chemistry Department (GSK) from 1st February 2023 until 4th March 2025. The confidentiality statement in this thesis does not apply.Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) is an intracellular aminopeptidase ...
Hryczanek, Ross Peter
core   +2 more sources

Allele frequencies of 11 ERAP1 SNPs.

open access: yes, 2020
Allele frequencies of 11 ERAP1 SNPs.
Parisa Riahi (8407764)   +9 more
core   +1 more source

Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion

open access: yesCell Reports, 2017
Herein, we demonstrate that HCMV miR-UL112-5p targets ERAP1, thereby inhibiting the processing and presentation of the HCMV pp65495-503 peptide to specific CTLs. In addition, we show that the rs17481334 G variant, naturally occurring in the ERAP1 3′ UTR,
Paolo Romania   +22 more
doaj   +1 more source

Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women

open access: yesScientific Reports, 2021
The clinical spectrum of hypertensive disorders of pregnancy (HDP) is determined by the interplay between environmental and genetic factors, most of which remains unknown.
Leonardo Capistrano Ferreira   +6 more
doaj   +1 more source

Polymorphisms in endoplasmic reticulum aminopeptidase genes are associated with cervical cancer risk in a Chinese Han population

open access: yesBMC Cancer, 2020
Background Antigen-processing machinery molecules play crucial roles in infectious diseases and cancers. Studies have shown that polymorphisms in endoplasmic reticulum aminopeptidase (ERAP) genes can influence the enzymatic activity of ERAP proteins and ...
Chuanyin Li   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy